The effectiveness of electroacupuncture for Parkinson's disease pain

A clinical randomized controlled study of electroacupuncture for Parkinson's skeletal muscle pain

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN24310308

Enrollment

Registered

2021-04-24

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal muscle pain in patients with Parkinson's disease Musculoskeletal Diseases

Interventions

Participants will be randomly allocated (1:1) to either the treatment or the control group. Treatment duration is 1 month with assessments at baseline (before the intervention), 2, and 4 weeks.

lower limb pain: Futu (ST32), Yanglingquan (SP9) + Ashi point

pierce 10-30 mm with stainless steel needles (1.5 inches of Huatuo brand), and when the patient has the feeling of “Deqi”, apply Huatuo brand SDZ-V EA apparatus (upper limbs: take Jianyu (LI15), Quchi

lower limbs: take Futu (ST32), Yanglingquan (SP9), choose the density wave, the frequency is 2 Hz Qod /100 Hz Qod, the needle is retained for 30 minutes. Control group:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Parkinson's disease and chronic musculoskeletal pain 2. Agrees to participate in the trial and signs an informed consent form 3. Aged between 30 and 80 years

Exclusion criteria

Exclusion criteria: 1. Severe heart, liver, kidney, or other organ dysfunction 2. Schizophrenia, malignant tumors, blood system, immune system, or metabolic dysfunction 3. Combined with other types of dementia (such as vascular dementia, frontotemporal dementia, or Alzheimer's disease) 4. Severe cognitive impairment and language impairment 5. Diagnosed with Parkinson's syndrome or Parkinson's superimposed syndrome 6. Poor treatment compliance or unable to cooperate with treatment 7. Do not agree to participate in this research 8. Physical pain caused by other diseases

Design outcomes

Primary

Measure	Time frame
Pain measured using King's Parkinson's Disease Pain Scale at baseline, 2, and 4 weeks	—

Secondary

Measure	Time frame
1. Pain measured using visual analogue scoring at baseline, 2, and 4 weeks 2. Daily life ability measured using Parkinson's composite score sheet at baseline, 2, and 4 weeks 3. Muscle tension measured using Modified Ashworth score at baseline, 2, and 4 weeks 4. Depression measured using Hamilton Depression Scale at baseline, 2, and 4 weeks 5. Muscle tension measured using real-time shear wave ultrasound elastography at baseline and 4 weeks	—

Measure

Time frame

1. Pain measured using visual analogue scoring at baseline, 2, and 4 weeks 2. Daily life ability measured using Parkinson's composite score sheet at baseline, 2, and 4 weeks 3. Muscle tension measured using Modified Ashworth score at baseline, 2, and 4 weeks 4. Depression measured using Hamilton Depression Scale at baseline, 2, and 4 weeks 5. Muscle tension measured using real-time shear wave ultrasound elastography at baseline and 4 weeks

—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026